(lp0
S'MiMedx Group Inc  Upgraded to B at TheStreet The Cerbat Gem - 14 hours ago MiMedx Group Inc logo TheStreet upgraded shares of MiMedx Group Inc  from a c+ rating to a b rating in a report published on Thursday.MiMedx Group Inc  Stock Rating Upgraded by TheStreet - Chaffey Breeze'
p1
aS"MiMedx To Present At Canaccord's 12th Annual Musculoskeletal Conference PR Newswire  - Mar 8, 2017 MARIETTA, Ga., March 8, 2017 /PRNewswire/ -- MiMedx Group, Inc. , the leading regenerative medicine company utilizing human placental tissue allografts and other birth tissues, human skin and bone, and patent-protected processes and&nbsp;...MiMedx Group Inc  Earns Overweight Rating from Analysts at Piper Jaffray ... - The Cerbat GemMiMedx Group, Inc.  held by 41 SEC 13F Filers - Post Analyst"
p2
aS'MiMedx Group, Inc.: A Fundamentally Solid Biomaterials Company Poised For Growth Seeking Alpha - Dec 9, 2016 I recommend buying a long position in MiMedx Group, Inc., trading at $8.29 per share at the time this analysis was conducted, as I believe the market is undervaluing this security by 30-40%.'
p3
aS'Stock Returns: Geron Corporation  versus MiMedx Group Inc (NASDAQ ... CML News - 12 hours ago This is a snapshot to compare the stock returns for Geron Corporation  versus MiMedx Group Inc  .'
p4
aS'MiMedx to Host Shareholder call on March 9, 2017 to present various strategic ... PR Newswire  - Mar 2, 2017 MARIETTA, Ga., March 2, 2017 /PRNewswire/ -- MiMedx Group, Inc. , the leading regenerative medicine company utilizing human placental tissue allografts and patent-protected processes to develop and market advanced products and&nbsp;...'
p5
aS'Option Market Alert: MiMedx Group Inc Implied Price Swing Hits An Amplified Level CML News - Mar 19, 2017 No Risk Alert Here: Before we dive into any analysis we simply note that MiMedx Group Inc  risk is neither elevated nor depressed.'
p6
aS'MiMedx Announces Nationwide Launch of New Ambient Temperature Version of OrthoFlo PR Newswire  - Jul 25, 2016 MARIETTA, Ga., July 25, 2016 /PRNewswire/ -- MiMedx Group, Inc. , the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to develop and market advanced products and therapies for&nbsp;...'
p7
aS'MiMedx Files Lawsuits Against Two Additional Former Sales Employees For Breach ... PR Newswire  - Dec 30, 2016 MARIETTA, Ga., Dec. 30, 2016 /PRNewswire/ -- MiMedx Group, Inc. , the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to develop and market advanced products and therapies for&nbsp;...'
p8
aS'Scientific Study Confirms MiMedx dHACM Allograft Promotes Cardiac Repair ... PR Newswire  - Jan 24, 2017 MARIETTA, Ga., Jan. 24, 2017 /PRNewswire/ -- MiMedx Group, Inc. , the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to develop and market advanced products and therapies for&nbsp;...MiMedx touts data from study of AmnioFix, EpiFix allograft - Mass Device'
p9
aS"MiMedx Board of Directors Authorizes $10 Million Increase to the Company's ... PR Newswire  - Feb 6, 2017 MARIETTA, Ga., Feb. 6, 2017 /PRNewswire/ -- MiMedx Group, Inc. , the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to develop and market advanced products and therapies for&nbsp;..."
p10
a.